Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus;Ocena wyrównania metobolicznego i bezpieczeństwa leczenia cia̧głym podskórnym wlewem insuliny małych dzieci z cukrzyca̧ typu 1

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 11, Issue 3, 2005, Pages 171-176

  Minkina Pȩdras, Mariola ^a   Jarosz Chobot, Przemysława ^a   Małecka Tendera, Ewa ^a   Deja, Grazyna ^a  

^a Klinika Pediatrii   (Poland)

Author keywords

Continuous subcutaneous insulin infusion (CSII); Prepubertal children; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PARAMETER; PREPUBERTY; SAFETY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INFUSION PUMP; INSULIN INFUSION; PRESCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; TIME FACTORS; TREATMENT OUTCOME;

EID: 25844434360     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bode B.W., Steed R.D., Davidson P.C.: Reduction in severe hypoglicemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care, 1996, 19, 324.
2. Bode B., Weinstein R., Bell D. i wsp.: Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion. Diabetes Care, 2002, 25, 439.
3. Boland E.: A flaxible option for adolescents with diabetes. Insulin pump therapy. Adv. Nurse Pract, 1998, 6, 38.
4. Boland E., Grey M., Oesterle A. i wsp.: Continuous subcutaneous insulin infusion. Diabetes Care, 1999, 22, 1779.
5. Bougneres P.P., Landier R, Lemmel C. i wsp.: Insulin pump therapy in young children with type 1 diabetes. J. Pediatr., 1984, 105, 212.
6. Celona-Jacobs N., Weinzimer S., Pearson M. i wsp.: Insulin pump therapy in children:cautionary tale (abstract). Diabetes, 50, 2001, supl. 2, A67.
7. Chantelau E., Schiffers T., Schutze J. i wsp.: Effect of patient-selected intensive insulin therapy on quality of life. Patient Educt. Couns., 1997, 30, 167.
8. Conrad S., McGrath M., Gitelman S.: Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J. Pediatr., 2002, 140, 235.
9. Davies A.G., Baum J.D.: A decade of insulin infusion pumps. Arch. Dis. Child., 1988, 63, 329.
10. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med., 2000, 342, 381.
11. Diabetes Control and Complications Trial Research Group: Implementation of treatment protocols in the Diabetes Control and Complications Trials. Diabetes Care, 1995, 18, 361.
12. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long - term complications in insulin - dependent diabetes mellitus. N. Engl. J. Med., 1993, 329, 977.
13. Hanas R.: Selection for and initiation of continuous subcutaneous insulin infusion. Horm. Res., 2002, 57, supl. 1, 101.
14. Kaufman F.R., Austin J., Neistein A. i wsp.: Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patient with type 1 diabetes. J. Pediatr., 2002, 141, 625.
15. Kaufman F.R., Halvorson M., Kim C. i wsp.: Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care, 2000, 23, 579.
16. Lepore G., Dodesini A., Nosari INICJAł i wsp.: Both continuous subcutaneous insulin infusion and multiple daily infusion regimen with glargine as basal insulin are equally better then traditional multiple daily insulin injection treatment. Diabetes Care. 2003, 26, 1321.
17. Litton J., Rice A., Friedman N. i wsp.: Insulin pump therapy in toddlers and pre-school children with type 1 dziabetes mellitus. J. Pediatr., 2002, 141, 490.
18. Maniatis A.K., Klingensmith G.J., Slover R.H. i wsp.: Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics, 2001, 107, 351.
19. Minkina-Pȩdras M., Muchacka-Bianga M., Jarosz-Chobot P. i wsp.: Doświadczenia własne w leczeniu dzieci z cukrzyca̧ typu 1 cia̧głym podskórnym wlewem insuliny. Diabetol. Dośw. i Klin., 2002, 2, 217.
20. Naf S., Esmatjes E., Recasens E. i wsp.: Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care, 2002, 25, 634.
21. Noczyńska A., Wa̧sikowa R.: Ocena leczenia cukrzycy typu 1 u dzieci i młodzieży przy pomocy osobistych pomp insulinowych. Diabetol. Pol., 2000, 7, 224.
22. Pańkowska E., Lipka M., Szypowska A. i wsp.: Wyrównanie metaboliczne u małych dzieci z cukrzyca̧ typu 1 leczonych metoda̧ cia̧głego podskórnego wlewu insuliny. Endokrynol. Diabetol. Chor. Przemiany Materii Wieku Rozwojow., 2003, 9, 11.
23. Pickup J., Keen H.: Continuous subcutaneous insulin infusion at 25 years. Diabetes Care, 2002, 25, 593.
24. Pickup J., Mattock M., Kerry S.: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ, 2002, 324, 705.
25. Plotnick L, Clark L.: Insulin pumps in children and adolescents. The Endocrinologist, 2001, 11, 112.
26. Plotnick L., Clark L., Brancati F. i wsp.: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care, 2003, 26, 1142.
27. Raile K., Noelle V., Landgraf R. i wsp.: Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy. J. Pediatr. Endocrinol. Metab., 2002, 15, 607.
28. Renner A., Trautmann M. i wsp.: use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CS II Study Group. Diabetes Care, 1999, 22, 784.
29. Reynolds L.R.: Reemergence of insulin pump therapy in the 1999s. South Med. J., 2000, 93, 1157.
30. Schade D., Valentine V.: To pump or not to pump. Diabetes Care, 2002, 25, 2100.
31. Steindel B., Roe T., Costin G. i wsp.: Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res. Clin. Pract., 1995, 27, 199.
32. Weissberg-Benchell J., Antisdel-Lomaglio J., Seshadri R.: Insulin pump therapy. Diabetes Care, 2003, 26, 1079.
33. Willi S.M., Planton J., Egede L. i wsp.: Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J. Pediatr., 2003, 143, 796.